Cargando…

Fcγ-Receptor IIIA Polymorphism p.158F Has No Negative Predictive Impact on Rituximab Therapy with and without Sequential Chemotherapy in CD20-Positive Posttransplant Lymphoproliferative Disorder

We retrospectively analyzed the p.V158F polymorphism of Fcγ-receptor IIIA (FCGR3A, CD16) in patients with PTLD treated with rituximab monotherapy. Previous reports had indicated that the lower affinity F allele affects rituximab-mediated antibody-dependent cellular cytotoxicity (ADCC) and is linked...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimmermann, Heiner, Weiland, Theresa, Nourse, Jamie P., Gandhi, Maher K., Reinke, Petra, Neuhaus, Ruth, Karbasiyan, Mohsen, Gärtner, Barbara, Anagnostopoulos, Ioannis, Riess, Hanno, Trappe, Ralf U., Oertel, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987796/ https://www.ncbi.nlm.nih.gov/pubmed/24741582 http://dx.doi.org/10.1155/2014/264723

Ejemplares similares

Posttransplant Lymphoproliferative Disorders
por: Ibrahim, Hazem A. H., et al.
Publicado: (2012)

Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort study
por: Walti, Laura N., et al.
Publicado: (2020)

Posttransplant lymphoproliferative disease presenting as jejunal perforation
por: Krishna, K. C., et al.
Publicado: (2009)

Posttransplant Lymphoproliferative Disease after Lung Transplantation
por: Neuringer, Isabel P.
Publicado: (2013)

Posttransplant Lymphoproliferative Disease Presenting as an Extracranial Mass
por: Arasaratnam, Reuben J., et al.
Publicado: (2017)

Sezary syndrome manifesting as posttransplant lymphoproliferative disorder
por: Afiat, Thanh-Phuong, et al.
Publicado: (2018)

Fc‐gamma IIIa‐V158F receptor polymorphism contributes to the severity of Guillain‐Barré syndrome
por: Hayat, Shoma, et al.
Publicado: (2020)

Plasmacytoma/multiple myeloma type posttransplant lymphoproliferative disorder
por: Claushuis, Theodora A.M., et al.
Publicado: (2022)

Hematopoietic Stem Cell Transplantation after Posttransplant Lymphoproliferative Disorder
por: Kim, Min Joo, et al.
Publicado: (2010)

Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation
por: Mynarek, Martin, et al.
Publicado: (2013)

Isolated Upper Extremity Posttransplant Lymphoproliferative Disorder in a Child
por: Halula, Sarah E., et al.
Publicado: (2015)

Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders
por: Dharnidharka, Vikas R., et al.
Publicado: (2019)

Thymic Hyperplasia after Lung Transplantation Imitating Posttransplant Lymphoproliferative Disorder
por: Steger, Christina Maria, et al.
Publicado: (2011)

Postrenal Transplant Metastatic Colonic Neoplasm: Posttransplant Lymphoproliferative Disorder or Adenocarcinoma?
por: Lal, H., et al.
Publicado: (2017)

Recurrent, Multisubtype Posttransplant Lymphoproliferative Disorder Masquerading as Inflammatory Bowel Disease
por: Mussarat, Saad, et al.
Publicado: (2022)

Bone marrow involvement by classic Hodgkin lymphoma posttransplant lymphoproliferative disorder
por: Lyapichev, Kirill A., et al.
Publicado: (2021)

Editorial: Infections and posttransplant lymphoproliferative disease after pediatric kidney transplantation
por: Kizilbash, Sarah J., et al.
Publicado: (2023)

P1560: EARLY DIAGNOSIS WITH EBV MONITOR AND PREEMPTIVE RITUXIMAB REDUCES POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER MORTALITY AND INCREASE OVERALL SURVIVAL AFTER ALLOGENEIC TRANSPLANTATION
por: Liu, Jia-Hau, et al.
Publicado: (2023)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder with Autologous Blood Stem Cell Transplant
por: Malhotra, Bharat, et al.
Publicado: (2015)

Posttransplant Lymphoproliferative Disorder Isolated to the Adrenal Gland in a Liver Transplant Patient
por: Ghaziani, Tara T., et al.
Publicado: (2018)

Posttransplant Lymphoproliferative Disorder in a Patient with Worsening Ascites after Liver Transplantation
por: Patel, Harsh D., et al.
Publicado: (2017)

Late-Onset Posttransplant Lymphoproliferative Disorders after Solid Organ Transplantation in Adults: A Case Series and Review of the Literature
por: Gandhi, S., et al.
Publicado: (2020)

Treatment of Recurrent Posttransplant Lymphoproliferative Disorder of the Central Nervous System with High-Dose Methotrexate
por: Twist, Clare J., et al.
Publicado: (2013)

Plasmacytoma-Like Posttransplant Lymphoproliferative Disease in a Disused Arteriovenous Fistula: The Importance of Histopathology
por: Kousios, Andreas, et al.
Publicado: (2019)

Posttransplant Lymphoproliferative Disorder: Experience from a Pediatric Nephrology Unit in North India
por: Thergaonkar, R. W., et al.
Publicado: (2018)

HLA Associations and Risk of Posttransplant Lymphoproliferative Disorder in a Danish Population-Based Cohort
por: Vase, Maja Ølholm, et al.
Publicado: (2015)

Incidence and clinical characteristics of posttransplant lymphoproliferative disorders: report from a single center
por: Muti, G., et al.
Publicado: (2000)

Late-Onset Posttransplant Lymphoproliferative Disorder Results in Jejunal Stricture Managed with Endoscopic Dilation
por: Park, Steven, et al.
Publicado: (2021)

Spontaneous regression of central nervous system posttransplant lymphoproliferative disease: A case report
por: Gao, Rupan, et al.
Publicado: (2021)

The weaker-binding Fc γ receptor IIIa F158 allotype retains sensitivity to N-glycan composition and exhibits a destabilized antibody-binding interface
por: Kremer, Paul G., et al.
Publicado: (2022)

Castleman's Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
por: Jha, Lokesh K., et al.
Publicado: (2018)

Early‐ and late‐onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients
por: Abdulovski, Ranya, et al.
Publicado: (2022)

Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS
por: Guney, Ekin, et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Posttransplant Lymphoproliferative Disorders Following Allogeneic Hematopoietic Stem Cell Transplantation in Korea
por: Park, Sun Hee, et al.
Publicado: (2006)

Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?
por: Morscio, J., et al.
Publicado: (2013)

Late Onset Epstein Barr Virus Seropositive Posttransplant Lymphoproliferative Disorder in Two Renal Transplant Receivers
por: Paydaş, Saime, et al.
Publicado: (2013)

Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center
por: Yoon, Ga Young, et al.
Publicado: (2015)

Posttransplant Lymphoproliferative Disorder in Adults Receiving Kidney Transplantation in British Columbia: A Retrospective Cohort Analysis
por: Ready, Erin, et al.
Publicado: (2018)

Fatal Case of EBV-negative Posttransplant Lymphoproliferative Disorder With Hemophagocytic Lymphohistiocytosis in an Adult Kidney Transplant Recipient
por: Mazzola Poli de Figueiredo, Sergio, et al.
Publicado: (2022)

Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease
por: Schultze-Florey, Rebecca E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ec6prbq4berum62c0cr3nogqmk